Literature DB >> 24426291

Camelpox, an emerging orthopox viral disease.

Vinayagamurthy Balamurugan1, Gnanavel Venkatesan2, Veerakyathappa Bhanuprakash3, Raj Kumar Singh4.   

Abstract

Camelpox is considered as emerging public health problem during this decade due to increased reported cases and outbreaks in camels. Camelpox is a contagious, often sporadic, and notifiable skin disease of camelids and is socio-economically significant as it incurs considerable loss in terms of morbidity, mortality, loss of weight and reduction in milk yield and confined to camel-rearing countries. The causative agent, camelpox virus (CMLV) is genetically closely related to variola virus and has gained much attention from researchers due to its recent emergence in human. The virus carrying genes responsible for host immune evasion mechanisms owing to the threat posed by potential bio-warfare agents. Although the disease can be diagnosed based on clinical features, the similar confounding skin lesions necessitate identification, detection and differentiation of the CMLV by molecular techniques. Vaccines are available in some countries and the available live attenuated vaccine provides long-lasting immunity. Further, novel highly sensitive and specific techniques would be useful in the identification of emerging and re-emerging virus, thereby therapeutic, prophylactic, preventive measures would be applied in time to curtail further spread of camelpox like other zoonotic diseases. This review provide overview of the camelpox particularly on its epidemiology, pathogenesis and biology of the disease, diagnostic approaches and control measures.

Entities:  

Keywords:  Biology; Camelpox virus; Control measures; Diagnosis; Epidemiology; Prophylaxis

Year:  2013        PMID: 24426291      PMCID: PMC3832703          DOI: 10.1007/s13337-013-0145-0

Source DB:  PubMed          Journal:  Indian J Virol        ISSN: 0970-2822


  65 in total

1.  Cryo-electron tomography of vaccinia virus.

Authors:  Marek Cyrklaff; Cristina Risco; Jose Jesús Fernández; Maria Victoria Jiménez; Mariano Estéban; Wolfgang Baumeister; José L Carrascosa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

2.  Serology of Orthopoxvirus cameli infection in dromedary camels: analysis by ELISA and western blotting.

Authors:  S M Azwai; S D Carter; Z Woldehiwet; U Wernery
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1996-01       Impact factor: 2.268

Review 3.  Camelpox virus.

Authors:  Sophie Duraffour; Hermann Meyer; Graciela Andrei; Robert Snoeck
Journal:  Antiviral Res       Date:  2011-09-16       Impact factor: 5.970

4.  Characterization of camelpoxvirus isolates from Africa and Asia.

Authors:  I C Renner-Müller; H Meyer; E Munz
Journal:  Vet Microbiol       Date:  1995-08       Impact factor: 3.293

Review 5.  Camelpox: epidemiology, diagnosis and control measures.

Authors:  Veerakyathappa Bhanuprakash; Manimuthu Prabhu; Gnanavel Venkatesan; Vinayagamurthy Balamurugan; Madhusudan Hosamani; Krishna M L Pathak; Raj Kumar Singh
Journal:  Expert Rev Anti Infect Ther       Date:  2010-10       Impact factor: 5.091

6.  Microarray analysis of mRNA levels from RAW264.7 macrophages infected with Brucella abortus.

Authors:  Linda Eskra; Angela Mathison; Gary Splitter
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

7.  A polymerase chain reaction strategy for the diagnosis of camelpox.

Authors:  Vinayagamurthy Balamurugan; Veerakyathappa Bhanuprakash; Madhusudhan Hosamani; Kallesh Danappa Jayappa; Gnanavel Venkatesan; Bina Chauhan; Raj Kumar Singh
Journal:  J Vet Diagn Invest       Date:  2009-03       Impact factor: 1.279

8.  PCR strategy for identification and differentiation of small pox and other orthopoxviruses.

Authors:  S L Ropp; Q Jin; J C Knight; R F Massung; J J Esposito
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

9.  Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines.

Authors:  E De Clercq; T Sakuma; M Baba; R Pauwels; J Balzarini; I Rosenberg; A Holý
Journal:  Antiviral Res       Date:  1987-12       Impact factor: 5.970

10.  Camelpox virus encodes a schlafen-like protein that affects orthopoxvirus virulence.

Authors:  Caroline Gubser; Rory Goodbody; Andrea Ecker; Gareth Brady; Luke A J O'Neill; Nathalie Jacobs; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2007-06       Impact factor: 3.891

View more
  7 in total

1.  Inactivation of indicator microorganisms and biological hazards by standard and/or alternative processing methods in Category 2 and 3 animal by-products and derived products to be used as organic fertilisers and/or soil improvers.

Authors:  Konstantinos Koutsoumanis; Ana Allende; Declan Bolton; Sara Bover-Cid; Marianne Chemaly; Robert Davies; Alessandra De Cesare; Lieve Herman; Friederike Hilbert; Roland Lindqvist; Maarten Nauta; Luisa Peixe; Giuseppe Ru; Marion Simmons; Panagiotis Skandamis; Elisabetta Suffredini; Benedetta Bottari; Enda Cummins; Kari Ylivainio; Irene Muñoz Guajardo; Angel Ortiz-Pelaez; Avelino Alvarez-Ordóñez
Journal:  EFSA J       Date:  2021-12-02

2.  First Diagnosed Case of Camelpox Virus in Israel.

Authors:  Oran Erster; Sharon Melamed; Nir Paran; Shay Weiss; Yevgeny Khinich; Boris Gelman; Aharon Solomony; Orly Laskar-Levy
Journal:  Viruses       Date:  2018-02-13       Impact factor: 5.048

Review 3.  Camel viral diseases: Current diagnostic, therapeutic, and preventive strategies.

Authors:  Mahmoud Kandeel; Abdullah I A Al-Mubarak
Journal:  Front Vet Sci       Date:  2022-08-11

4.  40 Years without Smallpox.

Authors:  G A Shchelkunova; S N Shchelkunov
Journal:  Acta Naturae       Date:  2017 Oct-Dec       Impact factor: 1.845

Review 5.  Poxvirus Host Range Genes and Virus-Host Spectrum: A Critical Review.

Authors:  Graziele Pereira Oliveira; Rodrigo Araújo Lima Rodrigues; Maurício Teixeira Lima; Betânia Paiva Drumond; Jônatas Santos Abrahão
Journal:  Viruses       Date:  2017-11-07       Impact factor: 5.048

6.  Genomic identification of human vaccinia virus keratoconjunctivitis and its importance as a laboratory-acquired infection.

Authors:  Zahra Movahedi Motlagh; Azam Mokhtari; Mohammadreza Mahzounieh
Journal:  Indian J Ophthalmol       Date:  2016-11       Impact factor: 1.848

Review 7.  Humanized Mice for Live-Attenuated Vaccine Research: From Unmet Potential to New Promises.

Authors:  Aoife K O'Connell; Florian Douam
Journal:  Vaccines (Basel)       Date:  2020-01-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.